Full-Time

Associate Scientist

Flow Cytometry

Posted on 10/31/2025

Altasciences

Altasciences

1,001-5,000 employees

Integrated CRO for early-phase drug development

No salary listed

Laval, QC, Canada

In Person

Category
Lab & Research (2)
,
Requirements
  • Ideally College degree and/or University degree in Chemistry, Biochemistry, Immunology or applicable field
  • Preferred experience in regulated clinical and/or preclinical studies with typically 3 year of experience
  • Knowledge of regulatory agency guidelines and must understand general SOPs and have good knowledge of GLP regulations
  • Good organizational skill
  • Highly flexible
  • Sense of urgency
  • Excellent troubleshooting skills
  • Client oriented
  • Attentive to details
  • Able to easily read and understand study plans and protocols, ability to coach/mentor people
  • Good communication both written and verbal in French & English
Responsibilities
  • Tabulate and perform final data batch review by performing multi-batch trend analysis, completing all study documentation as required including approving of Memo to File or SOP/Protocol/Study Plan deviations where appropriate.
  • Provide report and/or final results within study timelines and ensure any deviation, exception or events are reflected as appropriate and assure that all analysis conducted are reported and accurate.
  • Assist in writing validation and analytical plans/reports and provide comments and/or recommendations, as needed, for the bioanalytical portions of preclinical and clinical protocols, study plans, laboratory manuals, Data Transfer Agreements, and/or other document.
  • Assist for planning sample analysis by maintaining timeline and scheduling commitments.
  • If assigned, perform the ordering of reagents, materials and if assigned verification of inventory. Perform literature searches and draft work plans for the development of assays as assigned.
  • Assist with evaluation of risk and costing. Based on training and competency, perform laboratory bench work for method development or validation, interpretation of results, documentation/tabulation of data and troubleshooting when required.
  • Keeps BPI and/or Senior Scientist involved through ongoing communications.
  • Write, review and update method SOP as needed Support responses to QA reports Assigned by management on studies and tasks based on scientific competency and training (can include method development, validation or sample analysis projects).
  • Provide feedback on progress and assist in sponsor teleconferences as required.
  • Conduct all work in compliance with applicable SOPs, GCPs, GLPs and observes all company guidelines and policies.
  • Respecting Health and Safety standards in terms of personal protection, laboratory maintenance, and work procedures.

Altasciences provides an integrated CRO that handles the full early‑phase drug development path, from preclinical testing through clinical proof of concept and into manufacturing. Its approach combines discovery support, safety testing, clinical trial execution, and in‑house manufacturing to run programs under one roof. This contrasts with competitors that require pharma and biotech clients to source services from multiple vendors, adding complexity and risk; Altasciences streamlines the process by coordinating all steps. The company aims to help innovator drug programs move quickly and efficiently, delivering integrated data to de‑risk decisions and speed progression to later stages.

Company Size

1,001-5,000

Company Stage

Early VC

Total Funding

$6.7M

Headquarters

Laval, Canada

Founded

1976

Simplify Jobs

Simplify's Take

What believers are saying

  • Biotech/pharma consolidation demand for single-vendor early-phase development solutions increases.
  • 3D tissue technology adoption reduces animal testing costs and accelerates regulatory approval timelines.
  • Geographic footprint and participant database enable rapid enrollment for mid-size biopharma sponsors.

What critics are saying

  • Novo Holdings divesting Altasciences signals poor financial performance and operational cutbacks.
  • Charles River aggressive pricing on integrated packages captures 20% mid-size biopharma contracts.
  • AI-driven preclinical platforms from Insilico Medicine displace traditional animal safety pharmacology testing.

What makes Altasciences unique

  • Integrated CRO/CDMO spanning preclinical safety testing through Phase IV bioanalysis and manufacturing.
  • 9 North American facilities with 500,000+ participant database conducting 285+ trials annually.
  • VoxCell partnership integrates 3D tissue technology for human-relevant preclinical testing.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Employee Assistance & Telehealth Programs

Remote Work Options

Company News

GlobeNewswire
Mar 16th, 2026
Outlook Therapeutics Announces New $18.4 Million Non-Convertible Note Financing and Amendment to Existing Convertible Note

ISELIN, N.J., March 16, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard...

Business Wire
Aug 20th, 2025
Altasciences Receives EcoVadis Gold Medal for Environmental, Social, and Governance (ESG) Efforts

EcoVadis, the world's most trusted provider of business sustainability ratings, has collaborated closely with Altasciences to enhance its environmental, social, and governance (ESG) initiatives, underscoring the company's commitment to a sustainable future and a reduced environmental footprint.

Yahoo Finance
Jul 31st, 2025
Altasciences and VoxCell BioInnovation Announce Strategic Collaboration to Advance Preclinical Drug Development

This partnership combines Altasciences' comprehensive early-phase drug development capabilities with VoxCell's cutting-edge 3D tissue technology to offer a more predictive and human-relevant preclinical testing environment.

Postmedia Network
Mar 28th, 2025
Altasciences Receives 2025 CDMO Leadership Award in Small Molecule Dosage Form Category

For 14 years, Outsourced Pharma's CDMO Leadership Awards have recognized the top-performing contract development and manufacturing organizations based on comprehensive industry research, and feedback from sponsors.

BioSpace
May 29th, 2024
Altasciences Receives 2024 CRO Leadership Award for Capabilities

Altasciences receives 2024 CRO Leadership Award for Capabilities.

INACTIVE